|
|
NEW ON THE MARKET
|
|
Lixisenatide (LYXUMIA): the third GLP-1 receptor agonist in type 2 diabetes
New indication: tadalafil (CIALIS) against lower urinary tract symptoms secondary to benign prostatic hyperplasia
|
|
|
a-t READER'S QUESTIONS AND COMMENTS
|
|
Fumaric acid esters (FUMADERM) in psoriasis
Buccal midazolam (BUCCOLAM) against seizures in children and adolescents
New Data on pneumococcal vaccine in children
|
|
|
IN BRIEF
|
|
Antihistamine doxylamine approved for pregnant women experiencing nausea and vomiting
|
|
Guideline against misleading and trivialising tradenames
|
|
|
SIDE EFFECTS
|
|
Ophthalmic agents with phosphate buffers: corneal calcification
New restrictions in the use of strontium ranelate (PROTELOS
Cardiac harms and bleeding with cilostazol (PLETAL)
GLP-1 based therapies damage the pancreas
EMA recommends suspension of the marketing authorization of tetrazepam (MUSARIL, generics)
|
|
|
e a-t IN INTERNET
|
|
Vitamin C: risk of kidney stones increased
|
|